Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

406 articles

Keyword: mRNA therapeuticsClear keyword
Frontiers in pharmacology2026ReviewNon-viral Gene DeliveryDrug Delivery

1. Targeted delivery platforms for in vivo immune cell engineering: emerging strategies for cancer immunotherapy

Rachamala Hk, Atla S, Angom Rs

Cancer immunotherapy is a transformative technology allowing for the elimination of malignant cells through immune system stimulation; however, the large-scale clinical application of adoptive cellular therapy technologies is limited due to difficulties in ex vivo immune cell engineering, high costs, and complicated manufacturing process. Recently, in vivo immune cell engineering was discovered as an emerging approach that allows for the genetic reprogramming of immune cells in patients, thus circumventing many problems inherent to traditional cellular therapy technologies.

Read the article
Articles | Brilliant Blue Biosciences